Therapeutic Uses
Anti-Diabetic
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Melamine; 1,3,5-Triazine-2,4,6(1H,3H,5H)-triimine; 2,4,6-Triamino-1,2,3-triazine
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Metformin EP impurity D is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Metformin EP impurity D usage and description
Metformin EP impurity D is a residual impurity that can be found in Metformin, which is a commonly used oral anti-diabetic medication. Although Metformin is a highly effective medication, it can sometimes contain impurities such as Metformin EP impurity D.
Metformin EP impurity D is a chemical compound that is classified as a secondary amine. Its chemical name is N-(2-aminoethyl)-N-methylacetamide, and its molecular formula is C5H12N2O. This impurity is known to be a potential carcinogenic compound, which is why its presence in Metformin must be monitored and controlled.
The usage of Metformin EP impurity D is strictly regulated by the European Pharmacopeia, which sets the maximum allowable limit for this impurity. The acceptable limit of Metformin EP impurity D in Metformin is set to less than or equal to 0.1%. Any amount above this limit is considered to be unsafe and can pose a risk to the health of the patient.
To minimize the presence of Metformin EP impurity D in Metformin, manufacturers must adhere to strict quality control measures during the manufacturing process. They must also conduct regular testing and analysis of their products to ensure compliance with regulatory guidelines. Overall, the usage and chemical information of Metformin EP impurity D is important for the safety and efficacy of Metformin as a medication.
